PARP-1 Inhibitors and Their Emerging Role in the Treatment of Lung Cancer
Lung cancer is one of the leading causes of death worldwide. The standard of care for advanced small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) includes platinumbased chemotherapy.